These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 29524020)

  • 1. Cross regulation between mTOR signaling and O-GlcNAcylation.
    Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
    J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-Dysregulation of
    Very N; Vercoutter-Edouart AS; Lefebvre T; Hardivillé S; El Yazidi-Belkoura I
    Front Endocrinol (Lausanne); 2018; 9():602. PubMed ID: 30356686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein O-GlcNAcylation and the regulation of energy homeostasis: lessons from knock-out mouse models.
    Issad T; Al-Mukh H; Bouaboud A; Pagesy P
    J Biomed Sci; 2022 Sep; 29(1):64. PubMed ID: 36058931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
    Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
    Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.
    Raab S; Gadault A; Very N; Decourcelle A; Baldini S; Schulz C; Mortuaire M; Lemaire Q; Hardivillé S; Dehennaut V; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Panasyuk G; Lefebvre T
    Cell Mol Life Sci; 2021 Jul; 78(13):5397-5413. PubMed ID: 34046694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.
    Butkinaree C; Park K; Hart GW
    Biochim Biophys Acta; 2010 Feb; 1800(2):96-106. PubMed ID: 19647786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mTOR affects protein stability of OGT.
    Park S; Pak J; Jang I; Cho JW
    Biochem Biophys Res Commun; 2014 Oct; 453(2):208-12. PubMed ID: 24858682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate mammalian target of rapamycin inhibition induces autophagy in HTR8/SVneo cells via O-linked β-N-acetylglucosamine signaling.
    Zhang Q; Na Q; Song W
    J Obstet Gynaecol Res; 2017 Oct; 43(10):1585-1596. PubMed ID: 28691313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell Signaling.
    Cork GK; Thompson J; Slawson C
    Front Endocrinol (Lausanne); 2018; 9():522. PubMed ID: 30237786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
    Nagel AK; Ball LE
    Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of O-GlcNAcylation in stabilization of oncogenic factors.
    Makwana V; Ryan P; Patel B; Dukie SA; Rudrawar S
    Biochim Biophys Acta Gen Subj; 2019 Aug; 1863(8):1302-1317. PubMed ID: 31034911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy.
    Kim G; Cao L; Reece EA; Zhao Z
    Sci Rep; 2017 Sep; 7(1):11107. PubMed ID: 28894244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.
    Le Minh G; Reginato MJ
    Adv Cancer Res; 2023; 157():195-228. PubMed ID: 36725109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
    Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
    J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
    Goldberg H; Whiteside C; Fantus IG
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
    Isono T
    PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.